It is a pharma public limited company based in Nashik, Maharashtra, India, established in 2007.
2007 | Nashik, Maharashtra, India | ActiveKaytross Acg Lifesciences Limited, a active public limited company, was established on 07 June 2007 in Nashik, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24119MH2007PLC171416. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹7.50 M.
Formerly known as Kaytross Acg Lifesciences Private Limited, Albatross -Cp Lifesciences Private Limited. It upholds a compliant status. Employing 25 professional, Its leadership includes Aparna Chetan Patni (Director), Arvind Shankar Shivasharan (Director), Chetan Jawaharbhai Patni (Director). Past directors included Raaj Tulsani Hiranand, Girdhari Ramchand Tulsani, Piyush Mahendra Goda. It holds ₹3.50 Cr open charges and ₹5.00 Cr settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at B-22, Midc, Ambad,, Nashik, Maharashtra, 422010.
U24119MH2007PLC171416
171416
07 June 2007
₹7.50 M
₹7.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Kaytross Acg Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aparna Chetan Patni | Director | 12 May 2017 | Current |
| Arvind Shankar Shivasharan | Director | 07 Jun 2007 | Current |
| Chetan Jawaharbhai Patni | Director | 07 Jun 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Nov 2019 | Past |
| Pramod Abcsdd | Director | 31 May 2010 | Past |
| Pramod Abcsdd | Director | 11 Feb 2020 | Past |
| Pramod Abcsdd | Director | 12 May 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kaytross Acg Lifesciences Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 47.08% decrease. The company also saw a slight decrease in profitability, with a 1.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 131.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Kaytross Acg Lifesciences had a promoter holding of 99.87% and a public holding of 0.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹35,000,000.00
₹49,975,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Nov 2016 | Others | ₹1.00 Cr | Open |
| 09 Nov 2016 | Others | ₹2.50 Cr | Open |
| 03 Feb 2012 | The Saraswat Co-Op. Bank Ltd. | ₹3.00 M | Satisfied |
| 30 Mar 2010 | The Saraswat Co-Operative Bank Limited | ₹1.40 M | Satisfied |
| 08 May 2009 | The Saraswat Co-Operative Bank Ltd. | ₹1.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Kaytross Acg Lifesciences has a workforce of 25 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kaytross Acg Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaytross Acg Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Kaytross Acg Lifesciences Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.
Kaytross Acg Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was recorded as a recent event.
The activity Aparna Chetan Patni was appointed as a Director was appointed as a Director on 12 May 2017 & has been associated with this company since 8 years 6 months . was completed.
Progress on A charge registered on 03 Feb 2012 via Charge ID 10336758 with The Saraswat Co-Op. Bank Ltd. was fully satisfied on 09 Jan 2017. was documented.
A charge registered on 30 Mar 2010 via Charge ID 10212625 with The Saraswat Co-Operative Bank Limited was fully satisfied on 09 Jan 2017. was recorded as a recent event.
The activity A charge registered on 05 Mar 2009 via Charge ID 10148822 with The Saraswat Co-Operative Bank Limited was fully satisfied on 09 Jan 2017. was completed.
The CIN of Kaytross Acg Lifesciences Limited is U24119MH2007PLC171416.
Kaytross Acg Lifesciences Limited is headquartered at B-22, Midc, Ambad,, Nashik, Maharashtra, 422010.
Kaytross Acg Lifesciences Limited was incorporated on 07 June 2007.
The current directors of Kaytross Acg Lifesciences Limited are
The primary industry of Kaytross Acg Lifesciences Limited is Manufacturing.
Kaytross Acg Lifesciences Limited is unlisted.
The authorized capital of Kaytross Acg Lifesciences Limited is ₹7.50 M, and the paid-up capital is ₹7.50 M.
The compliance status of Kaytross Acg Lifesciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX